LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 532.3M
Enterprise Value 334.21M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)145.11
Price/Book (mrq)13.67
Enterprise Value/Revenue 3153.69
Enterprise Value/EBITDA 6-8.70

Trading Information

Stock Price History

Beta (3Y Monthly) 2.50
52-Week Change 3-56.27%
S&P500 52-Week Change 315.46%
52 Week High 31.6900
52 Week Low 30.3959
50-Day Moving Average 30.5434
200-Day Moving Average 30.7025

Share Statistics

Avg Vol (3 month) 394.36k
Avg Vol (10 day) 371.16k
Shares Outstanding 578.79M
Float 61.75M
% Held by Insiders 119.98%
% Held by Institutions 12.11%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/11
Last Split Date 3Dec. 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 31, 2019
Most Recent Quarter (mrq)Aug. 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,792.78%

Management Effectiveness

Return on Assets (ttm)-97.68%
Return on Equity (ttm)-170.46%

Income Statement

Revenue (ttm)222.61k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)29.90%
Gross Profit (ttm)192.53k
EBITDA -3.93M
Net Income Avi to Common (ttm)-4.1M
Diluted EPS (ttm)-0.0530
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.35M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.86
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-3.01M
Levered Free Cash Flow (ttm)-2.07M